Live tape
Top 8, mentions 7d17,525MSFT3,304 mentions▲ +0.08GOOGL2,684 mentions▲ +0.05AAPL2,291 mentions▲ +0.07META2,227 mentions▲ +0.04SPCX1,993 mentions▲ +0.06SNDK1,846 mentions▲ +0.06NVDA1,752 mentions▲ +0.07QQQ1,428 mentions▲ +0.04

Equity · Healthcare

BRKR

Bruker Corporation · NasdaqGS

$63.00 +5.00% 1D Finazon · prior-day close · Jul 28, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of BRKR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $36.78 on 1 May 2026 through $63.00 on 28 July 2026. Finazon · prior-day close.

Market cap $9.6B
52-week range $29.36 – $63.00
Avg volume 550.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

BRKR insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Jul 2026
Open-market buys 0
Open-market sells 3
Net sold $318K
Non-trade filings 4
Date Insider Type Shares Value
15 Jul 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Sell 2,000 $121K
15 Jun 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Sell 2,000 $110K
15 May 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Sell 2,000 $88K
Compensation mechanics (4 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Jul 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Option exercise 2,000 $44K
15 Jun 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Option exercise 2,000 $44K
15 May 2026 Bernard Thierry Director Award 2,886
15 May 2026 Munch Mark EXEC VP&PRES BRUKER NANO INC. Option exercise 2,000 $44K

BRKR reported financials

SEC EDGAR XBRL

BRKR reported revenue of $3.4B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$8.6M.

Figure Reported Period
Revenue $3.4B 31 Dec 2025 fiscal year
Net income −$8.6M 31 Dec 2025 fiscal year
Diluted EPS −$0.15 31 Dec 2025 fiscal year
Total assets $6.1B 31 Mar 2026 at period end
Total equity incl. minority interest $2.5B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

BRKR earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.02 —
31 Dec 2025 FY 2025 $-0.15 —
30 Sep 2025 Q3 2025 $-0.41 —
30 Jun 2025 Q2 2025 $0.05 —

Reported figures & scheduled dates · SEC EDGAR filings

BRKR institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a BRKR position for the quarter ended 31 Mar 2026 — a combined $215.0M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −19.3% shares 1,485,089 $53.6M
AQR Capital Management Added +2,514.1% shares 1,292,899 $45.9M
Balyasny Asset Management New position 1,159,040 $41.9M
Point72 Asset Management Trimmed −38.6% shares 952,873 $34.4M
Two Sigma Investments Added +46.1% shares 615,992 $22.2M
Citadel Advisors Trimmed −86.2% shares 195,873 $7.1M
Tudor Investment Corp Added +31.3% shares 140,000 $5.1M
Marshall Wace Trimmed −92.2% shares 85,440 $3.1M
D. E. Shaw & Co. Trimmed −85.5% shares 45,924 $1.7M

Source: SEC EDGAR 13F filings

BRKR fails-to-deliver

SEC CNS data

On 24 Jun 2026, 77 shares of BRKR failed to deliver (about $4K).

Settlement date Shares failed Notional % of shares out
24 Jun 2026 77 $4K <0.001%
22 Jun 2026 3,533 $202K 0.002%
18 Jun 2026 3,027 $166K 0.002%
17 Jun 2026 3,808 $212K 0.003%
15 Jun 2026 5,711 $310K 0.004%

Source: SEC fails-to-deliver (CNS) data